Oxytocin in Individuals With Spectrum Autism Disorders
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 18 May 2018
At a glance
- Drugs Oxytocin (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- Acronyms OxytocinASD
- 04 May 2018 Planned End Date changed from 29 Jul 2017 to 15 May 2018.
- 04 May 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Jun 2017 New trial record